http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2569690-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-28
filingDate 1985-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_329480adf1e4283903303b3ddc61d281
publicationDate 1986-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2569690-A1
titleOfInvention D, L-LYSINE SALT OF ACID 1- (4-CHLOROBENZOYL) -5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
abstract THE INVENTION RELATES TO THE NEW D, L-LYSINE SALT OF 1- (4-CHLOROBENZOYL) -5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC SALT PARTICULARLY SOLUBLE IN WATER AND TO COMPOSITIONS PHARMACEUTICALS WHICH MAY BE ADMINISTERED ORAL OR PARENTERAL, CONTAINING A THERAPEUTICALLY ACTIVE AMOUNT OF SAID SALT OF D, L-LYSINE. THESE COMPOSITIONS ARE ACTIVE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, ANKILOSANT SPONDYLITIS, DROPS AND OSTEOARTHRITIS THANKS TO THE ANTI-INFLAMMATORY, ANTIPYRETIC AND ANALGESIC ACTIVITY OF THE ACTIVE PRINCIPLE OF THE INVENTION.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2687673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9313770-A1
priorityDate 1984-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413386364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21904726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10986537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415710343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457231771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557733
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424496341

Total number of triples: 32.